BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: Co-beneldopa

Presentation	Product	Chemical substance	Chapter	Items dispensed
Co-beneldopa 25mg/100mg capsules 0409010K0AAAJAJ	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	48,940
Co-beneldopa 12.5mg/50mg capsules 0409010K0AAAIAI	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	46,533
Co-beneldopa 25mg/100mg modified-release capsules 0409010K0AAAFAF	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	27,179
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free 0409010K0AAAMAM	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	20,846
Co-beneldopa 25mg/100mg dispersible tablets sugar free 0409010K0AAALAL	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	9,749
Co-beneldopa 50mg/200mg capsules 0409010K0AAAKAK	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	4,985
Co-beneldopa 12.5mg/50mg/5ml oral suspension 0409010K0AAANAN	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	No data available
Co-beneldopa 25mg/100mg/5ml oral liquid 0409010K0AAAHAH	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	No data available
Co-beneldopa 25mg/6.25mg/5ml oral suspension 0409010K0AAAPAP	Co-beneldopa	Co-beneldopa (Benserazide/levodopa)	Central Nervous System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.